• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Monitoring of high-flow nasal cannula for SARS-CoV-2 severe pneumonia: less is more, better look at respiratory rate.

作者信息

Blez Damien, Soulier Anne, Bonnet Francis, Gayat Etienne, Garnier Marc

机构信息

GRC 29, APHP.6, DMU DREAM, Anesthesiology and Critical Care Department, Saint-Antoine Hospital, Sorbonne University, 184 rue du Faubourg Saint-Antoine, 75012, Paris, France.

APHP.7, DMU PARABOL, Anesthesiology and Intensive Care Department, Lariboisière Hospital, Paris University, Paris, France.

出版信息

Intensive Care Med. 2020 Nov;46(11):2094-2095. doi: 10.1007/s00134-020-06199-9. Epub 2020 Jul 31.

DOI:10.1007/s00134-020-06199-9
PMID:32737522
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7393342/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b48/7393342/7add84a51afa/134_2020_6199_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b48/7393342/7add84a51afa/134_2020_6199_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b48/7393342/7add84a51afa/134_2020_6199_Fig1_HTML.jpg

相似文献

1
Monitoring of high-flow nasal cannula for SARS-CoV-2 severe pneumonia: less is more, better look at respiratory rate.监测高流量鼻导管治疗新型冠状病毒肺炎重症患者：少即是多，更应关注呼吸频率。
Intensive Care Med. 2020 Nov;46(11):2094-2095. doi: 10.1007/s00134-020-06199-9. Epub 2020 Jul 31.
2
The utility of high-flow nasal cannula oxygen therapy in the management of respiratory failure secondary to COVID-19 pneumonia.高流量鼻导管氧疗在COVID-19肺炎继发呼吸衰竭管理中的应用
S Afr Med J. 2020 May 7;110(6):12941.
3
High flow nasal cannula is a good treatment option for COVID-19.高流量鼻导管吸氧是治疗新冠肺炎的一种不错的选择。
Heart Lung. 2020 Sep-Oct;49(5):444-445. doi: 10.1016/j.hrtlng.2020.03.018. Epub 2020 Apr 11.
4
Oxygen therapy via high flow nasal cannula in severe respiratory failure caused by Sars-Cov-2 infection: a real-life observational study.高流量鼻导管给氧治疗严重新型冠状病毒肺炎所致呼吸衰竭：一项真实世界观察性研究。
Ther Adv Respir Dis. 2020 Jan-Dec;14:1753466620963016. doi: 10.1177/1753466620963016.
5
Prediction of outcome of nasal high flow use during COVID-19-related acute hypoxemic respiratory failure.新型冠状病毒肺炎相关急性低氧性呼吸衰竭患者使用经鼻高流量氧疗的预后预测
Intensive Care Med. 2020 Oct;46(10):1924-1926. doi: 10.1007/s00134-020-06177-1. Epub 2020 Jul 15.
6
Alternatives to Invasive Ventilation in the COVID-19 Pandemic.新冠疫情期间有创通气的替代方案
JAMA. 2020 Jul 7;324(1):43-44. doi: 10.1001/jama.2020.9611.
7
High-flow nasal cannula for COVID-19 patients: risk of bio-aerosol dispersion.高流量鼻导管在 COVID-19 患者中的应用：生物气溶胶扩散的风险。
Eur Respir J. 2020 Oct 8;56(4). doi: 10.1183/13993003.03004-2020. Print 2020 Oct.
8
High-flow nasal cannula for COVID-19 patients: risk of bio-aerosol dispersion.高流量鼻导管在 COVID-19 患者中的应用：生物气溶胶扩散的风险。
Eur Respir J. 2020 Oct 8;56(4). doi: 10.1183/13993003.03136-2020. Print 2020 Oct.
9
Low-flow nasal cannula oxygen and potential nosocomial spread of COVID-19.低流量鼻导管吸氧与新型冠状病毒肺炎的潜在医院内传播
Br J Anaesth. 2020 Sep;125(3):e309-e310. doi: 10.1016/j.bja.2020.05.011. Epub 2020 May 18.
10
High-flow nasal cannula oxygen therapy to treat patients with hypoxemic acute respiratory failure consequent to SARS-CoV-2 infection.高流量鼻导管氧疗治疗 COVID-19 感染所致低氧血症急性呼吸衰竭患者。
Thorax. 2020 Nov;75(11):998-1000. doi: 10.1136/thoraxjnl-2020-214993. Epub 2020 Jul 23.

引用本文的文献

1
Assessment of mortality risk by respiratory rate-specific quartiles in mechanically ventilated patients with acute respiratory distress syndrome in Mexico.墨西哥急性呼吸窘迫综合征机械通气患者按呼吸频率特定四分位数评估死亡风险
Intern Emerg Med. 2025 Sep 15. doi: 10.1007/s11739-025-04112-0.
2
Development of a Prognostic Nomogram for Nonneutropenic Invasive Pulmonary Aspergillosis Based on Machine Learning.基于机器学习的非中性粒细胞减少侵袭性肺曲霉病预后列线图的开发
J Inflamm Res. 2024 Nov 26;17:9823-9835. doi: 10.2147/JIR.S499008. eCollection 2024.
3
"Comparative analysis of predictors of failure for high-flow nasal cannula in bronchiolitis".

本文引用的文献

1
COVID-19 critical illness pathophysiology driven by diffuse pulmonary thrombi and pulmonary endothelial dysfunction responsive to thrombolysis.由弥漫性肺血栓和对溶栓有反应的肺内皮功能障碍驱动的COVID-19危重病病理生理学。
Clin Transl Med. 2020 Jun;10(2):e44. doi: 10.1002/ctm2.44. Epub 2020 Jun 5.
2
The experience of high-flow nasal cannula in hospitalized patients with 2019 novel coronavirus-infected pneumonia in two hospitals of Chongqing, China.中国重庆两家医院对新型冠状病毒感染的肺炎住院患者使用高流量鼻导管的经验。
Ann Intensive Care. 2020 Mar 30;10(1):37. doi: 10.1186/s13613-020-00653-z.
3
Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention.
“毛细支气管炎中高流量鼻导管失败的预测因素的比较分析”。
PLoS One. 2024 Nov 21;19(11):e0309523. doi: 10.1371/journal.pone.0309523. eCollection 2024.
4
Racial Differences in Accuracy of Predictive Models for High-Flow Nasal Cannula Failure in COVID-19.种族差异对 COVID-19 高流量鼻导管失败预测模型准确性的影响。
Crit Care Explor. 2024 Mar 12;6(3):e1059. doi: 10.1097/CCE.0000000000001059. eCollection 2024 Mar.
5
High-Flow Nasal Cannula in COVID-19 Patients With Moderate to Severe Respiratory Distress: A Retrospective Analysis.高流量鼻导管给氧用于中重度呼吸窘迫的COVID-19患者：一项回顾性分析
Cureus. 2024 Jan 18;16(1):e52518. doi: 10.7759/cureus.52518. eCollection 2024 Jan.
6
External validation of the HACOR score and ROX index for predicting treatment failure in patients with coronavirus disease 2019 pneumonia managed on high-flow nasal cannula therapy: a multicenter retrospective observational study in Japan.用于预测接受高流量鼻导管治疗的2019冠状病毒病肺炎患者治疗失败的HACOR评分和ROX指数的外部验证：日本一项多中心回顾性观察研究
J Intensive Care. 2024 Feb 15;12(1):7. doi: 10.1186/s40560-024-00720-8.
7
ROX index performance to predict high-flow nasal oxygen outcome in Covid-19 related hypoxemic acute respiratory failure.ROX指数在预测新冠病毒疾病相关低氧性急性呼吸衰竭患者高流量鼻导管给氧结局中的表现
Ann Intensive Care. 2024 Jan 18;14(1):13. doi: 10.1186/s13613-023-01226-6.
8
The Validity of the ROX Index and APACHE II in Predicting Early, Late, and Non-Responses to Non-Invasive Ventilation in Patients with COVID-19 in a Low-Resource Setting.低资源环境下 ROX 指数和 APACHE II 对预测 COVID-19 患者无创通气早期、晚期和无反应的有效性。
Viruses. 2023 Nov 8;15(11):2231. doi: 10.3390/v15112231.
9
Performance of the ROX index in predicting high flow nasal cannula failure in COVID-19 patients: a systematic review and meta-analysis.ROX 指数预测 COVID-19 患者高流量鼻导管失败的性能：系统评价和荟萃分析。
Crit Care. 2023 Aug 21;27(1):320. doi: 10.1186/s13054-023-04567-7.
10
Lessons from COVID-19 in the management of acute respiratory failure.2019冠状病毒病在急性呼吸衰竭管理方面的经验教训。
Breathe (Sheff). 2023 Mar;19(1):230035. doi: 10.1183/20734735.0035-2023. Epub 2023 May 23.
中国2019年冠状病毒病（COVID-19）疫情的特征及重要经验教训：来自中国疾病预防控制中心72314例病例报告的总结
JAMA. 2020 Apr 7;323(13):1239-1242. doi: 10.1001/jama.2020.2648.
4
Nasal High-Flow Therapy: Role of Fi in the ROX Index.经鼻高流量治疗：Fi在ROX指数中的作用。
Am J Respir Crit Care Med. 2019 Jul 1;200(1):115-116. doi: 10.1164/rccm.201902-0376LE.
5
An Index Combining Respiratory Rate and Oxygenation to Predict Outcome of Nasal High-Flow Therapy.呼吸频率与氧合指数联合预测经鼻高流量治疗结局。
Am J Respir Crit Care Med. 2019 Jun 1;199(11):1368-1376. doi: 10.1164/rccm.201803-0589OC.
6
Predicting success of high-flow nasal cannula in pneumonia patients with hypoxemic respiratory failure: The utility of the ROX index.预测高流量鼻导管吸氧对低氧性呼吸衰竭肺炎患者的疗效：ROX指数的应用价值。
J Crit Care. 2016 Oct;35:200-5. doi: 10.1016/j.jcrc.2016.05.022. Epub 2016 May 31.
7
Failure of high-flow nasal cannula therapy may delay intubation and increase mortality.高流量鼻导管治疗失败可能会延迟插管并增加死亡率。
Intensive Care Med. 2015 Apr;41(4):623-32. doi: 10.1007/s00134-015-3693-5. Epub 2015 Feb 18.